Suppr超能文献

1943年至2013年丹麦视网膜母细胞瘤患者——基因检测及临床意义

Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications.

作者信息

Gregersen Pernille A, Urbak Steen F, Funding Mikkel, Overgaard Jens, Jensen Uffe B, Alsner Jan

机构信息

a Department of Experimental Clinical Oncology , Aarhus University Hospital , Denmark .

c Department of Clinical Genetics , Aarhus University Hospital , Denmark , and.

出版信息

Acta Oncol. 2016;55(4):412-7. doi: 10.3109/0284186X.2015.1099732. Epub 2015 Oct 23.

Abstract

BACKGROUND

In heritable retinoblastoma there is a 50% risk of transmitting the RB1 mutation, and offspring carriers have more than 90% risk of developing retinoblastoma. Today, all newly diagnosed retinoblastoma patients in Denmark are screened for mutations in RB1, as opposed to only a minority of patients diagnosed before DNA testing was offered. Knowledge of heredity increases the chance of early diagnosis in offspring, leading to improved prognosis. We present data from the Danish retinoblastoma patients that emphasize the need for genetic counseling and RB1 screening in all untested retinoblastoma survivors.

MATERIAL AND METHODS

Data are extracted from The Danish Ocular Oncology Group Database, a national population database containing data on all Danish retinoblastoma patients since 1943.

RESULTS

In total 323 retinoblastoma patients have been diagnosed between 1943 and 2013. Since 1963, the rate has been stable around 1 per 14 000 live births with 95% of the patients surviving their retinoblastoma. Stratifying data on the time of diagnosis and status of genetic testing, the number of screened patients gradually increased from 5% in the beginning of the period to 96% in the last five-year period. A cohort of 181 retinoblastoma survivors with sporadic disease (15% heritable) did not receive genetic testing. Since the introduction of routine testing, one of 14 sporadic unilateral patients tested (7%) has been identified with a germline mutation. Before routine testing, five additional sporadic unilateral patients have been identified as heritable.

CONCLUSION

Only a minority of Danish retinoblastoma patients diagnosed before routine genetic testing was offered have been RB1 screened. To counsel the remaining untested patients and their families sufficiently regarding the risk to offspring and elevated risk of second primary cancers, we recommend information and access to genetic counseling and RB1 screening. This has ethical, psychological and possible economic consequences, and should be handled with caution.

摘要

背景

在遗传性视网膜母细胞瘤中,存在50%的风险传递RB1突变,且携带突变的后代患视网膜母细胞瘤的风险超过90%。如今,丹麦所有新诊断的视网膜母细胞瘤患者都要进行RB1突变筛查,这与DNA检测出现之前只有少数患者接受诊断形成对比。了解遗传情况可增加后代早期诊断的机会,从而改善预后。我们展示了来自丹麦视网膜母细胞瘤患者的数据,强调了对所有未经检测的视网膜母细胞瘤幸存者进行遗传咨询和RB1筛查的必要性。

材料与方法

数据提取自丹麦眼肿瘤学组数据库,这是一个全国性的人口数据库,包含自1943年以来所有丹麦视网膜母细胞瘤患者的数据。

结果

1943年至2013年间共诊断出323例视网膜母细胞瘤患者。自1963年以来,发病率一直稳定在每14000例活产中有1例,95%的患者在患视网膜母细胞瘤后存活下来。根据诊断时间和基因检测状况对数据进行分层,接受筛查的患者数量从该时期开始时的5%逐渐增加到最后一个五年期的96%。一组181例散发型疾病(15%为遗传性)的视网膜母细胞瘤幸存者未接受基因检测。自引入常规检测以来,14例接受检测的散发型单侧患者中有1例(7%)被鉴定出存在种系突变。在常规检测之前,另外5例散发型单侧患者被鉴定为遗传性。

结论

在提供常规基因检测之前被诊断的丹麦视网膜母细胞瘤患者中,只有少数接受了RB1筛查。为了就后代风险和第二原发性癌症的高风险向其余未经检测的患者及其家属提供充分咨询,我们建议提供信息并提供遗传咨询和RB1筛查服务。这具有伦理、心理和可能的经济后果,应谨慎处理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验